Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29305
Abstract: This final report from the REMEDEE Registry assessed the long‐term safety and efficacy of the dual‐therapy COMBO stent in a large unselected patient population. read more here.
Keywords: remedee registry; therapy combo; combo stent; dual therapy ... See more keywords
Nine‐month angiographic and 2‐year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus‐eluting COMBO dual‐therapy stent versus a polymer‐free sirolimus‐eluting stent in Chinese patients
Sign Up to like & getrecommendations! Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29553
Abstract: We evaluated the safety and efficacy of the novel dual‐therapy sirolimus‐eluting and endothelial progenitor cell (EPC) capture COMBO stent. read more here.
Keywords: dual therapy; sirolimus; sirolimus eluting; nine month ... See more keywords
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30175
Abstract: To compare the efficacy and safety of the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS) and the sirolimus‐eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian Organization… read more here.
Keywords: cd34 antibody; dual therapy; stent; antibody covered ... See more keywords
Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01496-w
Abstract: Based on recent studies, we want to provoke thoughts on how to further optimize research on antiplatelet treatment in patients on oral anticoagulation (OAC). One in three patients suffering from atrial fibrillation (AF) develops concomitant… read more here.
Keywords: atrial fibrillation; trial; analysis; dual therapy ... See more keywords
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-020-01709-4
Abstract: Although 7-day triple therapy, consisting of vonoprazan, amoxicillin (AMO), and clarithromycin (CLA), is recommended for Helicobacter pylori (H. pylori) eradication in adults. However, the importance of reducing antibiotic use in pediatric patients is well recognized.… read more here.
Keywords: junior high; dual therapy; triple therapy; vonoprazan ... See more keywords
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the US and Europe: Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "Gastroenterology"
DOI: 10.1053/j.gastro.2022.05.055
Abstract: BACKGROUND AND AIMS Novel, effective treatments for Helicobacter pylori infection are needed. This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, versus standard treatment on H. pylori eradication in the US and Europe.… read more here.
Keywords: triple therapy; therapy; dual therapy; vonoprazan triple ... See more keywords
Endoscopic dual therapy for giant peptic ulcer hemorrhage.
Sign Up to like & getrecommendations! Published in 2018 at "Endoscopy"
DOI: 10.1055/a-0665-4142
Abstract: Upper gastrointestinal bleeding (UGIB) is a common condition with an incidence of 40−150 cases per 100000 inhabitants per year [1, 2]. Peptic ulcer represents the most common cause of UGIB and dual therapy seems to… read more here.
Keywords: peptic ulcer; giant peptic; dual therapy; bleeding ... See more keywords
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz059
Abstract: Abstract Aims After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of patients undergoing PCI due to acute coronary syndrome (ACS) or… read more here.
Keywords: 110 150; ticagrelor; dual therapy; dabigatran dual ... See more keywords
1766. Sustained Viral Suppression with Dolutegravir and Boosted Darunavir Dual Therapy Among Highly Treatment-Experienced Individuals
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy209.151
Abstract: Abstract Background The use of antiretroviral (ARV) dual therapy for treatment of HIV is increasing; raltegravir with boosted darunavir (bDRV) is recommended in certain clinical situations in DHHS guidelines. Dolutegravir (DTG) with bDRV has not… read more here.
Keywords: suppression; dual therapy; viral suppression; dtg bdrv ... See more keywords
Dual therapy for Helicobacter pylori infection
Sign Up to like & getrecommendations! Published in 2023 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002565
Abstract: Abstract Bismuth-containing quadruple therapy (BQT) has long been recommended for Helicobacter pylori (H. pylori) eradication in China. Meanwhile, in the latest national consensus in China, dual therapy (DT) comprising an acid suppressor and amoxicillin has… read more here.
Keywords: helicobacter pylori; pylori eradication; eradication; dual therapy ... See more keywords
Triple antithrombotic therapy and dual therapy – What is the evidence base?
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15257
Abstract: A 78-year-old woman with atrial fibrillation (AF) and hypertension presented to the emergency department with chest pain. Her medications include amlodipine 5 mg once daily and apixaban 5 mg twice daily. The admission ECG demonstrated… read more here.
Keywords: triple antithrombotic; therapy; dual therapy; therapy evidence ... See more keywords